- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.10. | Bayer names Christoph Koenen as its new CMO | ||
| 01.10. | Sanofi forges new $8bn pact with Regeneron | ||
| 01.10. | GLOBE model finalised, with narrowed scope and fewer savings | ||
| 01.10. | New Lilly combo tops tirzepatide for weight loss in diabetes | ||
| 30.09. | Apogee buy delivers eczema trial win for AbbVie | ||
| 30.09. | Two men charged with infiltrating fake Ozempic into US | ||
| 30.09. | Lilly fleshes out triple G data in diabetes and obesity | ||
| 30.09. | PhRMA hires ex-House Majority Leader Eric Cantor as its CEO | ||
| 29.09. | uniQure falls on long-term Huntington's gene therapy data | ||
| 29.09. | Novo turns to Hengrui for another oral obesity drug | ||
| 29.09. | Mirum puts Hepcludex in its sights with hep D readout | ||
| 29.09. | AZ takes stake in Summit Therapeutics in $2bn deal | ||
| 29.09. | FDA clears first drug for MCT8 deficiency | ||
| 28.09. | MSD takes a $400m bite of SciBrunch's KRAS drug | ||
| 28.09. | Roche culls myostatin candidate from obesity pipeline | ||
| 28.09. | Test could end uncertainty in inherited muscle diseases | ||
| 28.09. | AbbVie's Cerevel takeover delivers Parkinson's approval | ||
| 28.09. | MSD, Daiichi pull filing for lung cancer candidate I-DXd | ||
| 28.09. | FDA approves Mirum's oral drug for rare disease FOP | ||
| 25.09. | EU clears first drug therapy for rare disease cALD | ||
| 25.09. | FDA starts speedy review of Imfinzi in bladder cancer | ||
| 25.09. | FDA nominee Overton dodges questions on Trump influence | ||
| 25.09. | Wnt drug gives MSD first eye disease win after EyeBio deal | ||
| 24.09. | Australia starts probe into AI infiltration of Medicare | ||
| 24.09. | Lilly's rival to Novo's new Awiqli insulin gets FDA approval |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.